Applied Genetic (AGTC)

NASDAQ
0.272
-0.005(-1.88%)
After Hours
0.280
+0.008(+3.093%)
- Real-time Data
  • Volume:
    1,441,476
  • Day's Range:
    0.270 - 0.308
  • 52 wk Range:
    0.270 - 3.180
Trading near 52-week Low

Applied Genetic has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

AGTC Overview

Prev. Close
0.277
Day's Range
0.27-0.308
Revenue
-
Open
0.29
52 wk Range
0.27-3.18
EPS
-1.53
Volume
1,441,476
Market Cap
18.37M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,324,889
P/E Ratio
-0.177
Beta
1.26
1-Year Change
-90.98%
Shares Outstanding
67,632,195
Next Earnings Date
Nov 08, 2022
What is your sentiment on Applied Genetic?
or
Market is currently closed. Voting is open during market hours.

Applied Genetic News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Applied Genetic Analysis

Applied Genetic Company Profile

Applied Genetic Company Profile

Employees
83

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.

Read More

Analyst Price Target

Average8.250 (+2933.09% Upside)
High16
Low2
Price0.272
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • What s next ?
    0
    • Explain pls
      0
      • "AGTC Announces Pricing of $10 Million Underwritten Public Offering" at $0.6 / share
        0
    • whats going on guys??
      0
      • they are raising capital
        0
    • Great news!!!
      0
      • hoping this will keep going🚀
        0
        • Buying more
          0
          • Potential rocket , good setup added at $1,9 🚀
            0
            • This stock is dead
              0
              • Alcon is buying AGTC, is that true?
                0
                • Time to buy big time
                  0